1. Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis
   Ding Long et al, 2019, Pancreas CrossRef
2. Effect of a Low-Carbohydrate High-Fat Diet and a Single Bout of Exercise on Glucose Tolerance, Lipid Profile and Endothelial Function in Normal Weight Young Healthy Females
   Thorhildur Ditta Valsdottir et al, 2019, Frontiers in Physiology CrossRef
3. Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma
   Petra Schneiderova et al, 2017, Oncotarget CrossRef
4. Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA
   Qijie Ran et al, 2022, Frontiers in Oncology CrossRef
5. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression
   S Ciavarella et al, 2017, BMC Cancer CrossRef
6. Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review
   Paola Manzo et al, 2023, International Journal of Molecular Sciences CrossRef
7. The role of suPAR in kidney diseases
   Mirosław Śnit et al, 2017, Annales Academiae Medicae Silesiensis CrossRef
8. Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction
   Evangelos Terpos et al, 2020, Journal of Clinical Medicine CrossRef